Sharekhan

Entero Healthcare Solutions Ltd

Fri 12/06/2026,15:52:42 | NSE : ENTERO

₹ 1136.7020.40 (1.83%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1139.40

Previous Close

₹ 1116.30

Volume

52843

Mkt Cap ( Rs. Cr)

₹4946.71

High

₹ 1142.00

Low

₹ 1105.00

52 Week High

₹ 1390.00

52 Week Low

₹ 944.00

Book Value Per Share

₹ 388.03

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Entero Healthcare Solutions Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

1136.70

277

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

277

Option Chain

Analyzes market sentiment, predicts Entero Healthcare Solutions Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Entero Healthcare - Disclosure under SEBI Takeover Regulations

    12 Jun 2026, 8:10PM OrbiMed Asia III Mauritius Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of I
  • Entero Healthcare - Resignation of Director/KMP/SMP

    12 Jun 2026, 7:12PM Entero Healthcare Solutions Limited has informed the Exchange about Resignation of Director/KMP/SMP
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Resignation of Director

    12 Jun 2026, 7:08PM Resignation of Mr. Kevin Rohitbhai Daftary as Non- Executive Nominee Director of the company w.e.f. Jun 12, 2026.
  • Entero Healthcare - Resignation

    12 Jun 2026, 7:04PM Entero Healthcare Solutions Limited has informed the Exchange regarding Resignation of Mr KEVIN ROHITBHAI DAFTARY as Non- Executive Nominee Director o
  • Entero Healthcare - ESOP/ESOS/ESPS

    11 Jun 2026, 6:26PM Entero Healthcare Solutions Limited has informed the Exchange regarding Grant of 17500 Options.
  • Entero Healthcare - The Grant Of Fresh 17,500 (Seventeen Thousand Five Hundred) Employee Stock Options Under The Existing 'En

    11 Jun 2026, 6:24PM The grant of fresh 17,500 (Seventeen Thousand Five Hundred) Employee Stock Options under the existing 'Entero Employee Stock Option Plan 2023'.
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    11 Jun 2026, 6:23PM The Board has approved the allotment of 3,420 (Three Thousand Four Hundred and Twenty) Equity Shares of Rs. 10/- (Rupees Ten) each of the Company, to
  • Entero Healthcare - ESOP/ESOS/ESPS

    11 Jun 2026, 6:20PM Entero Healthcare Solutions Limited has informed the Exchange regarding Allotment of 3420 Shares.
  • Entero Healthcare - Board Meeting Outcome for Outcome Of Board Meeting

    11 Jun 2026, 6:13PM Outcome of Board Meeting held on June 11, 2026
  • Entero Healthcare - Outcome of Board Meeting

    11 Jun 2026, 6:09PM Entero Healthcare Solutions Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 11, 2026.
  • Entero Healthcare - Disclosure under SEBI Takeover Regulations

    9 Jun 2026, 11:50AM ÿPrabhat Agrawalÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial
  • Entero Healthcare - Disclosure under SEBI Takeover Regulations

    5 Jun 2026, 12:26PM ÿPrem Sethiÿhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acqui
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    2 Jun 2026, 3:00PM Transcript of Earnings Call / Conference Call
  • Entero Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Jun 2026, 3:00PM Entero Healthcare Solutions Limited has informed the Exchange about Transcript
  • Entero Healthcare - Clarification On Investor Queries Relating To Profit Attributable To Owners Of The Company And Minority I

    28 May 2026, 11:23PM Clarification on Investor Queries relating to profit attributable to owners of the Company and minority interest for the Quarter ended 31st March 2026
  • Entero Healthcare - Updates

    28 May 2026, 11:22PM Entero Healthcare Solutions Limited has informed the Exchange regarding Clarification on Investor Queries relating to profit attributable to owners of
  • Entero Healthcare - Copy of Newspaper Publication

    27 May 2026, 3:48PM Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    26 May 2026, 3:28PM Recording of Earnings Call/ Conference Call
  • Entero Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    26 May 2026, 3:28PM Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Investor Presentation

    25 May 2026, 10:27PM Investor Presentation for Audited Financial Results/Statements for the Quarter and Financial Year ended March 31, 2026.
  • Entero Healthcare - Investor Presentation

    25 May 2026, 10:24PM Entero Healthcare Solutions Limited has informed the Exchange about Investor Presentation
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    25 May 2026, 9:47PM The Board has approved allotment of 7,240 (Seven Thousand Two Hundred Forty) Equity Shares of Rs. 10/- (Rupees Ten) each of the Company, to the eligib
  • Entero Healthcare - Outcome of Board Meeting

    25 May 2026, 9:44PM Entero Healthcare Solutions Limited has informed the Exchange regarding Outcome of Board Meeting held on May 25, 2026.
  • Entero Healthcare - The Board Approved The Re-Appointment Of Internal Auditor M/S. Ernst & Young LLP ('EY') For The Next Fina

    25 May 2026, 9:38PM The Board approved the re-appointment of Internal Auditor M/s. Ernst & Young LLP ('EY') for the next financial year 2026-27.
  • Entero Healthcare - Change in Auditors

    25 May 2026, 9:37PM Entero Healthcare Solutions Limited has informed the Exchange regarding Change in Auditors of the company.
  • Entero Healthcare - The Grant Of Fresh 7,300 (Seven Thousand Three Hundred) Employee Stock Options Under The Existing 'Entero

    25 May 2026, 9:32PM The grant of fresh 7,300 (Seven Thousand Three Hundred) Employee Stock Options under the existing 'Entero Employee Stock Option Plan 2023'.
  • Entero Healthcare - Acquisition

    25 May 2026, 9:31PM Entero Healthcare Solutions Limited has informed the Exchange about Acquisition
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Change in Management

    25 May 2026, 9:27PM the Board approved the re-appointment of Mr. Sujesh Vasudevan (DIN: 08240092), Mr. Rajesh Shashikant Dalal (DIN: 03504969) and Ms. Sandhya Gadkari Sh
  • Entero Healthcare - Appointment

    25 May 2026, 9:26PM Entero Healthcare Solutions Limited has informed the Exchange regarding Appointment of Mr Sujesh Vasudevan as Non- Executive Independent Director of t
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Acquisition

    25 May 2026, 9:25PM Acquisition of Vishal Surgicals and Vishal Surgicals & Medicals, a Partnership Firm, through its subsidiary company Sai Pharma Distributors Private Li
  • Entero Healthcare - ESOP/ESOS/ESPS

    25 May 2026, 9:18PM Entero Healthcare Solutions Limited has informed the Exchange regarding Grant of 7300 Options.
  • Entero Healthcare - ESOP/ESOS/ESPS

    25 May 2026, 9:15PM Entero Healthcare Solutions Limited has informed the Exchange regarding Allotment of 7240 Shares.
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Allotment

    25 May 2026, 9:13PM The Board has approved allotment of 7,240 (Seven Thousand Two Hundred Forty) Equity Shares of Rs. 10/- (Rupees Ten) each of the Company, to the eligib
  • Entero Healthcare posts Q4 net profit of Rs 13.42 cr

    25 May 2026, 9:10PM The company reported standalone net profit during the quarter stood at Rs 13.42 crore compared to net loss of Rs 27.81 crore in the previous year quar
  • Entero Healthcare - Outcome of Board Meeting

    25 May 2026, 9:06PM Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Entero Healthcare - Board Meeting Outcome for Outcome Of Board Meeting May 25, 2026

    25 May 2026, 9:05PM Outcome of Board Meeting May 25, 2026
  • Entero Healthcare - Results - Financial Year 2025-26

    25 May 2026, 9:00PM Outcome of Board Meeting held on May 25, 2026
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    21 May 2026, 6:20PM Intimation of Earnings call on Audited Financial Results of the Company for the quarter and year ended March 31, 2026
  • Entero Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    21 May 2026, 6:20PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results/Statements

    18 May 2026, 7:00PM Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2026 ,inter alia, to c
  • Entero Healthcare - Amalgamation/Merger

    6 May 2026, 7:31PM Entero Healthcare Solutions Limited has informed the Exchange about Amalgamation/Merger
  • Entero Healthcare - Announcement under Regulation 30 (LODR)-Scheme of Arrangement

    6 May 2026, 7:30PM Confirmation order sanctioning the Scheme of Amalgamation
  • Entero Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    10 Apr 2026, 5:41PM As of March 2026, 52.42% is owned by Promoters and 47.58% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 14.41% and Fore
  • Entero Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Apr 2026, 3:50PM Entero Healthcare Solutions Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Entero Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Apr 2026, 3:48PM Certificate u/r 74(5) of SEBI(DP) Regulations, 2018 for the quarter ended March 31, 2026
  • Entero Healthcare - Trading Window

    23 Mar 2026, 5:29PM Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) R

Key fundamentals

Evaluate the intrinsic value of Entero Healthcare Solutions Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 1790.715 1650.38 1626.414 675.232 581.205
Liabilities 1790.715 1650.38 1626.414 675.232 581.205
Equity 43.511 43.508 43.494 4.112 3.85
Gross Profit -62.71 -30.346 -34.494 -43.916 -53.716
Net Profit 26.875 19.181 38.44 -12.455 -40.847
Cash From Operating Activities -59.722 -109.016 -75.65 -56.909 -44.698
NPM(%) 7.71 4.69 12.08 -7 -29.75
Revenue 348.241 408.67 318.161 177.69 137.286
Expenses 410.951 439.016 352.655 221.606 191.002
ROE(%) 1.59 1.13 2.27 -0.73 -2.41

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Entero Healthcare Solutions Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 725.60 4.43 0.00 638.27 -26.19 0.69
Lotus Eye Hospital and Institute Ltd 135.10 0.65 4503.33 2325.75 0.39 0.00
Vaishali Pharma Ltd 7.14 -0.56 23.03 14590.23 15.96 0.00
Astec Lifesciences Ltd 769.60 -0.25 0.00 2193.24 -363.14 0.00

Company Info

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Read More

Parent Organisation

Entero Healthcare Solutions Ltd.

Founded

10/01/2018

Managing Director

Mr.Prabhat Agrawal

NSE Symbol

ENTEROEQ

FAQ

The current price of Entero Healthcare Solutions Ltd is ₹ 1136.70.

The 52-week high for Entero Healthcare Solutions Ltd is ₹ 1142.00 and the 52-week low is ₹ 1105.00.

The market capitalization of Entero Healthcare Solutions Ltd is currently ₹ 4946.71. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Entero Healthcare Solutions Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Entero Healthcare Solutions Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Entero Healthcare Solutions Ltd shares.

The CEO of Entero Healthcare Solutions Ltd is Mr.Prabhat Agrawal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT